Independence Trust’s GSK GSK Stock Holding History

Independence Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,975	Closed	-$239K	–	82
2015 Q3	$239K	Sell	4,975 -7,457	-60%	-$388K	0.25%	83
2015 Q2	$647K	Hold	12,432	–	–	0.44%	42
2015 Q1	$717K	Hold	12,432	–	–	0.45%	43
2014 Q4	$664K	Buy	12,432 +4,176	+51%	+$234K	0.4%	49
2014 Q3	$474K	Buy	8,256 +740	+10%	+$45.4K	0.31%	57
2014 Q2	$502K	Hold	7,516	–	–	0.32%	57
2014 Q1	$502K	Buy	7,516 +968	+15%	+$65.4K	0.35%	49
2013 Q4	$437K	Buy	6,548 +2,492	+61%	+$162K	0.3%	53
2013 Q3	$254K	Hold	4,056	–	–	0.19%	86
2013 Q2	$253K	Buy	+4,056	New	+$257K	0.18%	83

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Independence Trust's GSK Position: Q4 2015 in Review

Independence Trust sold out of GSK (GSK) in Q4 2015, closing a stake of 4,975 shares — an estimated $239K sold.

Independence Trust first reported a position in GSK in Q2 2013 and held it in 10 quarters. The position peaked at $717K in Q1 2015. 718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

Independence Trust reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
Independence Trust sold 4,975 GSK shares in Q4 2015, an estimated $239K.
Independence Trust first reported a position in GSK in Q2 2013 and held it in 10 quarters.
Independence Trust's GSK position peaked at $717K in Q1 2015.
718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Independence Trust's 13F filing for Q4 2015, filed 29 Jan 2016.